Literature DB >> 14609147

Blood pressure and rate pressure product response in males using high-dose anabolic androgenic steroids (AAS).

F Grace1, N Sculthorpe, J Baker, B Davies.   

Abstract

The literature regarding the blood pressure response to AAS use is equivocal. In addition, there is currently little data available on the Rate Pressure Product (RPP) response to anabolic androgenic steroids (AAS) use. The experimental aim of this study was to investigate the effects of AAS administration in combination with resistance training on blood pressure and rate pressure product in male amateur bodybuilders and compare the results with a morphologically matched, resistance trained control group. Subjects were divided into two groups (n=16 AAS users; n=16 controls). Systolic and Diastolic Blood Pressure, RPP. Resting Heart Rate and Body Composition measurements were obtained before (Pre), during (During) and 6-8 weeks following (Post) the AAS cycle in the AAS users with similar time intervals for the control group. No significant cardiovascular or morphological changes in the control group were found throughout the study. Significant increases in both diastolic (P<0.01) and mean arterial blood pressures (P<0.05) were found from Pre to Post cycle in the AAS group. RPP also increased significantly (P<0.01) from pre to post AAS cycle. All cardiovascular parameters returned to normal baseline measurements between 6 and 8 weeks post cycle. No blood pressure measurements throughout the study were consistent with clinically defined hypertension. The findings indicate that the AAS group exhibited significant increases in standard cardiovascular measurements compared with the control bodybuilders, and provides a contraindication to AAS use especially in borderline hypertensives.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609147     DOI: 10.1016/s1440-2440(03)80024-5

Source DB:  PubMed          Journal:  J Sci Med Sport        ISSN: 1878-1861            Impact factor:   4.319


  8 in total

Review 1.  Transhumanism, medical technology and slippery slopes.

Authors:  M J McNamee; S D Edwards
Journal:  J Med Ethics       Date:  2006-09       Impact factor: 2.903

Review 2.  Effects of androgenic-anabolic steroids in athletes.

Authors:  Fred Hartgens; Harm Kuipers
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

3.  Nasal steroid perspective: knowledge and attitudes.

Authors:  Cemal Cingi; Murat Songu
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-21       Impact factor: 2.503

4.  Effects of resistance training on ventricular function and hypertrophy in a rat model.

Authors:  Valério Garrone Barauna; Kaleizu Teodoro Rosa; Maria Cláudia Irigoyen; Edilamar Menezes de Oliveira
Journal:  Clin Med Res       Date:  2007-06

5.  Androgenic anabolic steroid, cocaine and amphetamine abuse and adverse cardiovascular effects.

Authors:  Efren Martinez-Quintana; Beatriz Saiz-Udaeta; Natalia Marrero-Negrin; Xavier Lopez-Mérida; Fayna Rodriguez-Gonzalez; Vicente Nieto-Lago
Journal:  Int J Endocrinol Metab       Date:  2013-10-01

6.  Androgenic-anabolic steroids inhibited post-exercise hypotension: a case control study.

Authors:  Jefferson F C R Junior; Alexandre S Silva; Glêbia A Cardoso; Valmir O Silvino; Maria C C Martins; Marcos A P Santos
Journal:  Braz J Phys Ther       Date:  2017-07-11       Impact factor: 3.377

7.  Echocardiographic findings in power athletes abusing anabolic androgenic steroids.

Authors:  Behzad Hajimoradi; Hashem Kazerani
Journal:  Asian J Sports Med       Date:  2012-09-29

8.  Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome.

Authors:  Edgar D Torres Fernandez; Kristen V Adams; Maryam Syed; Rodrigo O Maranon; Damian G Romero; Licy L Yanes Cardozo
Journal:  J Endocr Soc       Date:  2018-07-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.